Sharemaestro Newsreel

Have Kestra Medical Technologies Insiders Been Selling Stock?

Kestra Medical Technologies founder Brian Webster recently sold shares worth approximately US$692k, accounting for 7.1% of his holding. While this was the largest insider sale in the past year, the selling price was below the current market price, which can be seen as a …

Q3 EPS Estimates for AngioDynamics Reduced by Zacks Research

Moody National Bank Trust Division Makes New Investment in Repligen Corporation $RGEN

Moody National Bank Trust Division has acquired a new stake in Repligen Corporation (NASDAQ:RGEN), purchasing 17,728 shares valued at approximately $2.42 million. This investment comes as institutional investors collectively own 97.64% of the biotechnology company. Repligen recently reported strong quarterly earnings, exceeding analyst expectations …

The 5 Most Interesting Analyst Questions From Align Technology’s Q2 Earnings Call

Align Technology's Q2 results showed growth in Clear Aligner volumes and stable North American performance, with strong international expansion. Despite this, management noted softness in the Systems and Services segment due to shifts towards lower-cost scanner models. Analysts focused on how Align maintains high …

Levi & Korsinsky Reminds Embecta Corp. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 17, 2026 - EMBC

Levi & Korsinsky, LLP is reminding Embecta Corp. (NASDAQ: EMBC) investors of a pending class action lawsuit with a lead plaintiff deadline of August 17, 2026. The lawsuit alleges that Embecta made misleading statements regarding its fiscal year 2026 revenue guidance and U.S. pen …

ETFs Investing in Warby Parker, Inc. Class A Stocks

This article lists various Exchange Traded Funds (ETFs) that hold Warby Parker, Inc. Class A (WRBY) stocks. It provides a detailed table including each ETF's market value, weight of WRBY stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, …

Royal Bank of Canada Sells 18,448 Shares of LeMaitre Vascular, Inc. $LMAT

Royal Bank of Canada reduced its stake in LeMaitre Vascular, Inc. (LMAT) by 6.3% in the first quarter, selling 18,448 shares but still retaining a significant holding of 272,654 shares valued at $29.8 million. This comes as LeMaitre Vascular reported Q2 earnings that missed …

Lazard Asset Management LLC Purchases New Position in Stevanato Group S.p.A. $STVN

Lazard Asset Management LLC has acquired a new position in Stevanato Group S.p.A. (NYSE:STVN), purchasing 127,166 shares valued at approximately $1.75 million in the first quarter. Several other institutional investors also increased their holdings in the company. Stevanato Group reported a revenue increase of …

Stevanato Group SpA (STVN) (Q2 2026) Earnings Call Highlights: Biologics Surge and Alina ...

Stevanato Group (STVN) reported an 8% revenue increase in Q2 2026, driven by a 9% rise in biopharmaceutical and diagnostic solutions and a 30% surge in biologics revenue. The company saw an adjusted EBITDA margin expansion to 26% and achieved a significant milestone with …

Alcon (ALC) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Alcon (ALC) is projected to report Q2 earnings of $0.77 per share, a 1.3% increase year-over-year, with revenues expected to hit $2.77 billion, up 7.3%. Analysts are closely monitoring key metrics like Net Sales for Total Surgical ($1.55 billion) and Total Vision Care ($1.21 …

Lazard Asset Management LLC Purchases Shares of 9,738 AptarGroup, Inc. $ATR

Lazard Asset Management LLC acquired 9,738 shares of AptarGroup, Inc. (NYSE:ATR) worth approximately $1.23 million in the first quarter, adding to significant institutional ownership. Despite positive sentiment from recent earnings beats, a dividend announcement, and analyst upgrades, insider selling, including a $1.34 million sale …

AngioDynamics, Inc. $ANGO Shares Purchased by Lazard Asset Management LLC

Lazard Asset Management LLC significantly increased its stake in AngioDynamics, Inc. (NASDAQ:ANGO) by 1,328.2% during the first quarter, now owning 154,578 shares valued at $1.76 million. This comes as AngioDynamics exceeded Q1 earnings expectations, reporting an adjusted loss of $0.07 per share on $86.61 …

ResMed (RMD) Q2 Earnings: What To Expect

5 Insightful Analyst Questions From Avantor’s Q2 Earnings Call

Nyxoah SA Revenue Breakdown – MUN:5YI

Nyxoah SA generated 10.02 million EUR in revenue last year, primarily from its "Innovative Solutions" segment, which contributed the entire amount. Germany was the largest geographical contributor, accounting for 4.49 million EUR of the company's revenue. This represents an increase from the previous year's …

Utah Medical Products, Inc. Announces Quarterly Dividend of $0.31 (NASDAQ:UTMD)

Azenta, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:AZTA) 2026-08-05

Envista (NVST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Envista (NVST) Q2 Earnings and Revenues Surpass Estimates

Strength Seen in Kestra Medical Technologies, Ltd. (KMTS): Can Its 8.1% Jump Turn into More Strength?

Solventum Corp (SOLV) (Q2 2026) Earnings Call Highlights: Strong Growth and Strategic ... By GuruFocus

Solventum Corp (SOLV) reported strong Q2 2026 results, exceeding expectations with significant organic growth across all segments and raised its full-year guidance. The company announced the separation of its Health Information Systems (HIS) business to focus on medtech and enhance shareholder value, while also …

Medline (MDLN) Stock Faces Margin Strain Despite Double Digit Revenue Growth

Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc. (SMTI) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Sanara MedTech Inc. (SMTI) on behalf of investors. This investigation follows a 24.7% stock price drop on November 12, 2026, after Sanara announced the discontinuation of its Tissue Health Plus program, incurring a $26.5 …

LeMaitre Vascular Inc (LMAT) (Q2 2026) Earnings Call Highlights: Strong EPS Growth and ...

Teleflex (TFX) Q2 Earnings Report Preview: What To Look For

Solventum outruns medical-supplies peers with a 9.5% week, yet volume has not fully endorsed the move

SOLV closed at 85.44 USD, within 3.6% of its 52-week high, with an active weekly trend but only 0.9x 13-week volume confirmation.

ICU Medical (ICUI) Reports Q2: Everything You Need To Know Ahead Of Earnings

ICU Medical (ICUI) is scheduled to report its Q2 earnings this Thursday after market close. The market anticipates a 2% year-on-year revenue decline, an improvement from last year's 6.4% decrease. The company has a history of surpassing Wall Street expectations and its stock is …

ICU Medical, Inc. (ICUI) Stock Analysis: Assessing Growth Potential And Analyst Consensus

ICU Medical, Inc. (ICUI), a key player in medical instruments with a $4.32 billion market cap, shows a positive stock recovery over the past year, trading above moving averages. Despite a 12.30% revenue contraction, the company boasts a robust $387 million free cash flow …

Warren Foust Named President and CEO of STAAR Surgical, Deborah Andrews Transitions to Executive Vice President and CFO Roles

STAAR Surgical Company has appointed Warren Foust as its new President, Chief Executive Officer, and a board member, effective August 4, 2026. Foust previously served as interim co-CEO, president, and chief operating officer. Deborah Andrews, who served as interim co-CEO alongside Foust, will transition …

Is Becton Dickinson (BDX) Undervalued As Its Brazil Semaglutide Partnership Fuels Growth Hopes?

Becton Dickinson (BDX) is gaining attention due to its recent partnership with EMS to launch a semaglutide therapy in Brazil using its Vystra injection pen. Despite a 10.92% share price return over 90 days, the stock is down 15.04% year-to-date and trades below analyst …

Stevanato Group (STVN) Stock Faces Cash Strain Despite Margin Gains

What To Expect From Warby Parker’s (WRBY) Q2 Earnings

Earnings Preview: BNGO to Report Financial Results Post-market on August 10

Bionano Genomics (BNGO) is scheduled to report its financial results on August 10 after the market closes. Analysts are anticipating a loss of $0.06 per share on revenue of $10.14 million for the quarter. This release will provide investors with an update on the …

Earnings To Watch: Dentsply Sirona (XRAY) Reports Q2 Results Tomorrow

Kaplan Fox Deadline Alert: Embecta Corp. (NASDAQ: EMBC) Investors Have Until August 17, 2026 to Seek a Lead Plaintiff Role

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit stems from a significant drop in Embecta's stock price after the …

Stevanato (STVN) Q2 2026 Earnings Call Transcript

Stevanato Group (STVN) reported an 8% revenue increase in Q2 2026, driven by a 9% rise in biopharmaceutical and diagnostic solutions and a 30% surge in biologics revenue. The company saw an adjusted EBITDA margin expansion to 26% and achieved a significant milestone with …